Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...
Hosted on MSN
Experts finally find treatment for incurable viral infection suffered by 122million Americans
Half of Americans are suffering from an incurable disease that causes painful - and embarrassing - blisters and sores around the mouth. About 122million people have herpes simplex virus 1 (HSV-1), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results